![Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial]()
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trialTang, Lin-Quan; Chen, Dong-Ping; Guo, Ling; Mo, Hao-Yuan; Huang, Ying; Guo, Shan-Shan; Qi, Bin; Tang, Qing-Nan; Wang, Pan; Li, Xiao-Yun; Li, Ji-Bin; Liu, Qing; Gao, Yuan-Hong; Xie, Fang-Yun; Liu, Li-Ting; Li, Yang; Liu, Sai-Lan; Xie, Hao-Jun; Liang, Yu-Jing; Sun, Xue-Song; Yan, Jin-Jie; Wu, Yi-Shan; Luo, Dong-Hua; Huang, Pei-Yu; Xiang, Yan-Qun; Sun, Rui; Chen, Ming-Yuan; Lv, Xing; Wang, Lin; Xia, Wei-Xiong; Zhao, Chong; Cao, Ka-Jia; Qian, Chao-Nan; Guo, Xiang; Hong, Ming-Huang; Nie, Zhi-Qiang; Chen, Qiu-Yan; Mai, Hai-Qiang · The Lancet Oncology · 2018